Company profilePharmaceutical#251 of 1,318 in Pakistan2 DRAP alerts

Brookes Pharmaceutical Labs (Pvt) Ltd.

Pharmaceutical company · 72 brands · 70 molecules

Ranked #12 of 74 companies in Pain Management

72 registered products 28 pharmaceutical brands 70 distinct molecules 2 DRAP alerts

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

Brookes Pharmaceutical Labs (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 72 product registrations across 70 distinct molecules. Its portfolio is concentrated in Pain Management and Skin Conditions. DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Brookes

48 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Skin Conditions 8

Oxoferinsolntop50mlRs 523.42 Pyodine Topical10% 450MlRs 1,520 Pyodinescrub450mlRs 460.18 Pyodinescrub60mlRs 93.35 Pyodinesoln450mlRs 461 Pyodinesoln60mlRs 85.67 PyodinetopicalRs 1,520 Pyodinetopical450mlRs 1,520

Antiinflammatory And Antirheumatic Products 7

Arnil50mgRs 71.3 Arnil75mgRs 150 Phlogin50MgRs 381 Phlogin1% 20gRs 114 Phlogin3mlRs 175 Phlogin100mgRs 483.2 Phlogin20gRs 114

General 5

EczemusointRs 424.3 HepamerzgranulesRs 455 Hepamerzinf10mlRs 307.56 Minoxinsoln60mlRs 500 Minoxinsolnplus60mlRs 668.54

Antiseptics And Disinfectants 4

Pyodine10% 60MlRs 237.5 Pyodine5% 20GRs 194.77 Pyodine20gRs 205.02 Pyodine60mlRs 250

Pain Management 3

Arnilp50mgRs 65 Neopyrolate1mlRs 1,136.6 PhlogintopicalRs 80

Antipsoriatics 3

Eczemus0.1% 10GRs 1,140 Eczemus0.03% 10gRs 491.61 Eczemus10gRs 517.48

Top molecules by brand count

Povidone-Iodine4 brands

Minoxidil3 brands

Diclofenac Sodium3 brands

Doxofylline2 brands

Acyclovir2 brands

Neostigmine2 brands

Ornithine Aspartate2 brands

Terbinafine2 brands

Ketoconazole2 brands

Buprenorphine2 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official1 products · Rs 3,096.19 – Rs 3,096.19

DVAGO13 products · Rs 71.3 – Rs 3,325

Servaid29 products · Rs 65 – Rs 1,157.17

Median across source: Rs 401

Regulatory record

2 alerts in the DRAP feed we track.

Voluntary Recall Alert: Drug Product; Neo-Pyrolate Injection (Batch # 105B24) Manufactured

2024-10-28

Voluntary Recall Alert: Drug Product; Cadlec 30mg/mL Injection by Brooks Pharma Pvt Ltd.,

2024-05-29

Competitive set

Companies whose registered portfolio overlaps most with this one.

VALOR PHARMACEUTICALS25 shared molecules

BIO LABS (PVT) LTD.25 shared molecules

SHROOQ PHARMACEUTICALS25 shared molecules

Global Pharmaceuticals Pakistan24 shared molecules

NEUTRO PHARMA (PVT) LTD.24 shared molecules

SAFFRON PHARMACEUTICAL COMPANY21 shared molecules

MEDERA PHARMACEUTICALS (PVT) LTD.21 shared molecules

INDUS PHARMA (PVT) LTD.20 shared molecules

SAMI PHARMACEUTICALS (PVT) LTD.20 shared molecules

Atco Pharma International (Pvt) Ltd19 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

VALOR PHARMACEUTICALS holds 151 molecules not in this portfolio

BIO LABS (PVT) LTD. holds 134 molecules not in this portfolio

SHROOQ PHARMACEUTICALS holds 19 molecules not in this portfolio

Get the full profile for Brookes

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included